PINK1 promotes the progression of lung squamous cell carcinoma through the FAK/AKT/RhoA/vinculin pathway
Oncology Reports · 2026
DOI: 10.3892/or.2026.9201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2026. Verfasst von Xu Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shan…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Squamous Cell, Protein Kinases. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, Shanxi 030032, P.R. China.
- Department of Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, Shanxi 030032, P.R. China.
Zitieren
APA
Li, X., & Ma, Y. (2026). PINK1 promotes the progression of lung squamous cell carcinoma through the FAK/AKT/RhoA/vinculin pathway. Oncology Reports. https://doi.org/10.3892/or.2026.9201
Vancouver
Li X, Ma Y. PINK1 promotes the progression of lung squamous cell carcinoma through the FAK/AKT/RhoA/vinculin pathway. Oncology Reports. 2026. doi:10.3892/or.2026.9201
BibTeX
@article{Li2026,
author = {Li, Xu and Ma, Yuhui},
title = {PINK1 promotes the progression of lung squamous cell carcinoma through the FAK/AKT/RhoA/vinculin pathway},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9201}
}
EUVIMED